IP Library › Granted Patent US 7,094,589
Granted Patent B2
US 7,094,589 · App. 10/674,636 · Granted Aug 22, 2006

53010, A novel human carboxylesterase family member and uses thereof

Assignee: Millennium Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,094,589
App. No.
10/674,636
Granted
Aug 22, 2006
Kind
B2
Abstract

The invention provides isolated nucleic acids molecules, designated 53010 nucleic acid molecules, which encode novel carboxylesterase members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 53010 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 53010 gene has been introduced or disrupted. The invention still further provides isolated 53010 proteins, fusion proteins, antigenic peptides and anti-53010 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

Claims (8)

1. An isolated polypeptide comprising an amino acid sequence having at least 95% sequence identity to the entire length of the amino acid sequence of SEQ ID NO:2, wherein the amino acid sequence has carboxylesterase activity.

2. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:2.

3. An isolated polypeptide consisting of the amino acid sequence of SEQ ID NO:2.

4. An isolated polypeptide which is encoded by a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO: 1.

5. The polypeptide of claim 1 , further comprising heterologous amino acid sequences.

6. The polypeptide of claim 2 , further comprising heterologous amino acid sequences.

7. The polypeptide of claim 3 , further comprising heterologous amino acid sequences.

8. The polypeptide of claim 4 , further comprising heterologous amino acid sequences.

Continuity (4)
Division 1002351500 · Dec 18, 2001
Provisional Application 6025636900 · Dec 18, 2000
Provisional Application 6027950800 · Mar 28, 2001
Related Publication 20040086922A1 · May 6, 2004